Skip to main content
. 2010 Sep 3;1(4):320–331.

Table 1.

Characteristics of study participants *

Nurses Health Studies NECC


Characteristic Cases Controls P§ Cases Controls P§
N 233 663 1120 1160
Mean (SD) Mean (SD)
Age (yrs) § § 59.4 (9.9) 59.2 (10.0) 51.7 (12.7) 51.1(12.9)
BMI (Kg/m2) 26.0 (5.5) 25.6 (4.7) 26.3 (6.3) 25.7(5.5) **
Parity 3.0(1.3) 3.2(1.5) ** 2.6 (1.3) 2.8 (1.5) **
Duration of OC (mos) † † 47.8 (41.6) 53.9 (48.9) 53.1(54.7) 60.9 (55.3) **
Age at menarche (yrs) 12.7 (1.5) 12.5 (1.4) 12.6 (1.5) 12.7 (1.6)
Age at first birth (yrs) 25.1(3.8) 24.9 (3.3) 24.7 (5.0) 25.1 (5.0)
% %
Nulliparous 11.2 7.5 32.0 18.7 **
Breastfeeding (18+ mos) 11.8 15.3 8.7 13.6 **
Postmenopausal § § 73.8 70.9 52.1 49.9
Current smoker 11.2 10.3 22.0 19.7
History of tubal ligation 15.5 21.4 ** 13.8 18.2 **
Hystory of hysterectomy 19.7 16.7 8.2 8.5
Family history of ovarian cancer 7.3 3.3 ** 5.0 2.9 **
Family history of breast cancer 13.3 13.7 14.2 12.0
Regular use any NSAIDs ‡ ‡ 39.1 37.3 18.4 21.8 **
CYP2C9 R144C/ I359L ‖ ‖ 37.0 36.1 34.4 34.6
UGT1A6 T181A/R184S ‖ ‖ 56.5 60.0 57.6 58.1
COX-2 765G>C/Ex10+837T>C ‖ ‖ 59.0 56.0 54.0 56.2
*

Restricted to Caucasians and to those with genotyping data.

Includes epithelial ovarian cancer cases (incident and prevalent cases diagnosed ≤4years of blood collection) and their matched controls

Characteristics ascertained 2-4 years (NHS/NHS-II) and 1 year (NECC) prior to ovarian cancer diagnosis

§

P-values adjusted for matching factors

§ §

Matching factor (only NHS/NHSII matched on menopausal status)

**

P-value<0.05

Among parous participants

† †

Among partipants who ever used oral contraceptives (OC)

‡ ‡

Regular user if 2+ times a week (NHS/NHS-II) or 2+ tablets/week (NECC)

‖ ‖

Any variant allele